rs34598902

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BS2BP4BA1

This summary comes from the ClinGen Evidence Repository: NM_000180.4(GUCY2D):c.2101C>T (p.Pro701Ser) is a missense variant that is predicted to replace proline at position p.701 with serine. This variant is present in gnomAD v.4.1.0 at a Grpmax allele frequency of 0.2041, with 9318 / 44874 alleles in the East Asian population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in 2099 adult individuals in gnomAD which exceeds the LCA/eoRD VCEP threshold of >6 (gnomAD version 4.1.0; BS2). The computational predictor REVEL gives a score of 0.27, which is below the ClinGen LCA / eoRD VCEP threshold of <0.290 and predicts a non-damaging effect on RetGC-1 protein function. In addition, the splicing impact predictor SpliceAI gives a delta score of 0, which is below the ClinGen LCA/eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP:BA1, BS2, BP4 (VCEP specifications version 1.0.0; date of approval 01/22/2025). LINK:https://erepo.genome.network/evrepo/ui/classification/CA200657/MONDO:0100453/167

Frequency

Genomes: 𝑓 0.039 ( 255 hom., cov: 32)
Exomes 𝑓: 0.033 ( 1844 hom. )

Consequence

GUCY2D
NM_000180.4 missense

Scores

3
15

Clinical Significance

Benign reviewed by expert panel B:12O:1

Conservation

PhyloP100: 2.92
Variant links:
Genes affected
GUCY2D (HGNC:4689): (guanylate cyclase 2D, retinal) This gene encodes a retina-specific guanylate cyclase, which is a member of the membrane guanylyl cyclase family. Like other membrane guanylyl cyclases, this enzyme has a hydrophobic amino-terminal signal sequence followed by a large extracellular domain, a single membrane spanning domain, a kinase homology domain, and a guanylyl cyclase catalytic domain. In contrast to other membrane guanylyl cyclases, this enzyme is not activated by natriuretic peptides. Mutations in this gene result in Leber congenital amaurosis and cone-rod dystrophy-6 diseases. [provided by RefSeq, Dec 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
For more information check the summary or visit ClinGen Evidence Repository.
BS2
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GUCY2DNM_000180.4 linkc.2101C>T p.Pro701Ser missense_variant Exon 10 of 20 ENST00000254854.5 NP_000171.1 Q02846
GUCY2DXM_011523816.2 linkc.2101C>T p.Pro701Ser missense_variant Exon 9 of 19 XP_011522118.1 Q02846

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GUCY2DENST00000254854.5 linkc.2101C>T p.Pro701Ser missense_variant Exon 10 of 20 1 NM_000180.4 ENSP00000254854.4 Q02846

Frequencies

GnomAD3 genomes
AF:
0.0395
AC:
6004
AN:
152180
Hom.:
254
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0333
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0648
Gnomad ASJ
AF:
0.0222
Gnomad EAS
AF:
0.221
Gnomad SAS
AF:
0.0921
Gnomad FIN
AF:
0.0407
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0210
Gnomad OTH
AF:
0.0397
GnomAD3 exomes
AF:
0.0527
AC:
13104
AN:
248670
Hom.:
683
AF XY:
0.0526
AC XY:
7088
AN XY:
134724
show subpopulations
Gnomad AFR exome
AF:
0.0362
Gnomad AMR exome
AF:
0.0637
Gnomad ASJ exome
AF:
0.0238
Gnomad EAS exome
AF:
0.212
Gnomad SAS exome
AF:
0.0897
Gnomad FIN exome
AF:
0.0389
Gnomad NFE exome
AF:
0.0214
Gnomad OTH exome
AF:
0.0415
GnomAD4 exome
AF:
0.0332
AC:
48458
AN:
1460890
Hom.:
1844
Cov.:
33
AF XY:
0.0346
AC XY:
25146
AN XY:
726712
show subpopulations
Gnomad4 AFR exome
AF:
0.0350
Gnomad4 AMR exome
AF:
0.0624
Gnomad4 ASJ exome
AF:
0.0217
Gnomad4 EAS exome
AF:
0.206
Gnomad4 SAS exome
AF:
0.0907
Gnomad4 FIN exome
AF:
0.0368
Gnomad4 NFE exome
AF:
0.0207
Gnomad4 OTH exome
AF:
0.0448
GnomAD4 genome
AF:
0.0395
AC:
6012
AN:
152298
Hom.:
255
Cov.:
32
AF XY:
0.0434
AC XY:
3236
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.0334
Gnomad4 AMR
AF:
0.0649
Gnomad4 ASJ
AF:
0.0222
Gnomad4 EAS
AF:
0.221
Gnomad4 SAS
AF:
0.0921
Gnomad4 FIN
AF:
0.0407
Gnomad4 NFE
AF:
0.0210
Gnomad4 OTH
AF:
0.0402
Alfa
AF:
0.0302
Hom.:
351
Bravo
AF:
0.0400
TwinsUK
AF:
0.0189
AC:
70
ALSPAC
AF:
0.0218
AC:
84
ESP6500AA
AF:
0.0388
AC:
171
ESP6500EA
AF:
0.0192
AC:
165
ExAC
AF:
0.0511
AC:
6200
Asia WGS
AF:
0.159
AC:
551
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:12Other:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Benign:4Other:1
-
Department of Ophthalmology and Visual Sciences Kyoto University
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: literature only

- -

Nov 29, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Retina International
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

- -

Nov 12, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 27884173, 11035546, 23424971, 20981092, 18055820, 15111605) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:3
Oct 03, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in 1000Genomes: 180/2178=8.2% -

-
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Leber congenital amaurosis 1 Benign:1
-
Laboratory of Genetics in Ophthalmology, Institut Imagine
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: research

- -

Cone-rod dystrophy 6;C2931258:Leber congenital amaurosis 1 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

GUCY2D-related recessive retinopathy Benign:1
Jan 30, 2025
ClinGen Leber Congenital Amaurosis/early Onset Retinal Dystrophy Variant Curation Expert Panel, ClinGen
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

NM_000180.4(GUCY2D):c.2101C>T (p.Pro701Ser) is a missense variant that is predicted to replace proline at position p.701 with serine. This variant is present in gnomAD v.4.1.0 at a Grpmax allele frequency of 0.2041, with 9318 / 44874 alleles in the East Asian population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.016 (BA1). This variant has been found in the homozygous state in 2099 adult individuals in gnomAD which exceeds the LCA/eoRD VCEP threshold of >6 (gnomAD version 4.1.0; BS2). The computational predictor REVEL gives a score of 0.27, which is below the ClinGen LCA / eoRD VCEP threshold of <0.290 and predicts a non-damaging effect on RetGC-1 protein function. In addition, the splicing impact predictor SpliceAI gives a delta score of 0, which is below the ClinGen LCA/eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4). In summary, this variant meets the criteria to be classified as Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP:BA1, BS2, BP4 (VCEP specifications version 1.0.0; date of approval 01/22/2025). -

Cone-rod dystrophy 6;C2931258:Leber congenital amaurosis 1;C4551884:Choroidal dystrophy, central areolar, 1;C5231408:Night blindness, congenital stationary, type1i Benign:1
Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Retinal dystrophy Benign:1
Jan 01, 2018
Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.54
D
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.49
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.54
T
MetaRNN
Benign
0.0065
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-4.1
D
REVEL
Benign
0.27
Sift
Benign
0.15
T
Sift4G
Benign
0.29
T
Polyphen
0.79
P
Vest4
0.15
MPC
0.68
ClinPred
0.030
T
GERP RS
4.4
Varity_R
0.088
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34598902; hg19: chr17-7915912; COSMIC: COSV54694803; COSMIC: COSV54694803; API